Skip to content
Open access

P-448: Clinical characteristics, metabolic features, and early microvascular complications in young-onset diabetes: insights from bach mai hospital, a tertiary referral center

Nov 2026 · Hormone Research in Paediatrics · 0 citations

Abstract

Young-onset diabetes is associated with early complications, yet Southeast Asian data are scarce. To describe diabetes subtypes, metabolic features, treatment patterns, and microvascular complications in young-onset diabetes. In a cross-sectional study, 246 participants diagnosed with diabetes between ages 18 and 35 years and enrolled at ages 18 - 45 years were recruited from January 2024 to August 2025. Clinical, biochemical, and complication data were analyzed. The study population had a male-to-female ratio of 1:1.14, with no statistically significant difference between genders (p > 0.05). Mean age at diagnosis was 28.1 ± 5.7 years. Type 2 diabetes (T2D) predominated (72.0%), followed by type 1 (T1D) (17.1%), pancreatogenic diabetes (8.9%) and other types (2.0%). At diagnosis, compared with T2D, patients with T1D were diagnosed younger (22.8 ± 5.5 vs 28.9 ± 5.1 years, p < 0.001) and had a higher prevalence of diabetic ketoacidosis at presentation (78.6% vs 17.5%, p < 0.001). Mean HbA1c was 9.2 ± 2.7%, with only 15.9% achieving the individualized HbA1c target of < 6.5%. Obesity, fatty liver disease, dyslipidemia, and hypertension were present in 34.1%, 63.0%, 86.6%, and 20.3%, respectively. Preventive treatment remained suboptimal, with only 64.0% of hypertensive patients receiving antihypertensive therapy and 44.1% of those with dyslipidemia receiving lipid-lowering treatment. Regarding microvascular complications, diabetic kidney disease, retinopathy, and neuropathy were present in 27.6%, 16.7%, and 26.4%, respectively. Overall, 42.3% had ≥ 1 microvascular complication and 8.9% had all three. The first microvascular complication occurred after 4.7 ± 3.7 years, earlier in T2D than T1D (4.1 vs 7.3 years, p = 0.002). Young-onset diabetes was characterized by poor glycemic control, high cardiometabolic burden, undertreatment of risk factors and early microvascular complications, supporting early screening and intensive multifactorial care.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.